Searched for
PHARMA SECTOR
Quant Mid Cap Fund exits ICICI Bank, 2 others and adds 5 stocks in AugustQuant Mid Cap Fund exited ICICI Bank, Ambuja Cements and L&T Technology Services in August, while adding six stocks including IDBI Bank, Co...- Sensex rises 400 points, Nifty nears 23,250 as investors await Fed meeting outcome. What to expect?Sensex and Nifty rebounded around 0.5% on Wednesday after Tuesday’s selloff wiped out more than Rs 9 lakh crore from Dalal Street. Investor...
- MFs raise healthcare bets for 4th straight month to 71-month high. Should investors follow?Mutual funds raised their healthcare allocation for the fourth straight month in August 2026 to 8.4%, the highest in 71 months. Experts att...
- Gorilla investing and 34% return: How Mihir Vora made Trust Smallcap Fund top performerTrust Smallcap Fund has emerged as the best performing fund in its category over the past year, delivering a 34% return as investors reasse...
- Spike in crude prices, US yields brings India’s m-cap below $5 trillionIndian stock markets experienced a significant decline on Tuesday. Crude oil prices surged above one hundred dollars a barrel. United State...
- Short-term headwind? Yes. But the structure stays intact: 5 large-cap stocks with upside potential of up to 19%Wise men on the street will tell you it is foolish to try and time the market. And attempting to do so in the midst of a raging war is prob...
- Weekly Market Outlook: Can Nifty find its footing as crude, Fed policy drive markets?Indian equities enter a holiday-shortened week with the Nifty at a crucial support zone after five consecutive weekly declines. The US Fed’...
- Dalal Street Week Ahead: Weak technical setup to keep bulls under pressureThe technical structure has deteriorated following the violation of the important 23,900–24,000 support zone. This area had provided suppor...
- Explained: Why did market bounce back? Sensex recovers 620 points from day’s low, Nifty closes near 23,400On Friday, Indian stock indices bounced back notably after a sluggish start, largely due to declining oil prices and bond yields. The shift...
- Midcap rally hides a deeper split: Every second stock down but index up 11% in 1 year. Are investors walking on thin ice?The Nifty Midcap 150 has gained around 11% over the past year, outperforming the Nifty’s 6% decline. However, the gains have been uneven, w...
- US sanctions on Iran: Basmati demand stays strong, pharma and livestock exporters face new hurdlesIranian demand for Indian basmati remains resilient despite tougher US sanctions, but exporters are facing rising shipping, insurance, and ...
- Why DSP Mutual Fund's Chirag Dagli is betting on CDMO, hospitals and smallcap healthcare stocksAt the same time, the fund is evaluating hospital expansion, hybrid diagnostics businesses and valuations to identify healthcare companies ...
- Manufacturing firms' factory leasing seen rising to 30-32 million sq ft annually by 2030: ReportFactory space leasing in India is projected to reach thirty to thirty-two million square feet annually by 2030. This growth is fueled by ca...
- Tata Capital Healthcare Fund to exit Linux Laboratories as ChrysCapital buys 20-25% stakePrivate equity firm ChrysCapital is set to acquire a significant stake in Linux Laboratories. This deal will see existing investor Tata Cap...
- India white-collar hiring rises 14% in August, led by auto, healthcare and retailIn August, white-collar job opportunities in Mumbai surged by fourteen percent from last year. This growth was largely propelled by strong ...
- B2B startup Fundly.ai raises $4 million led by Accel, MultiplyMumbai-based B2B pharma distribution platform Fundly.ai has raised $4 million from existing investors Accel and Multiply, along with ventur...
- Pharma sector must attract more investment in clinical trials, R&D: Piyush GoyalPiyush Goyal emphasized the importance of enhancing India's pharmaceutical industry to draw in more investments. He urged for the creation ...
- FII money trail: Where did overseas investors put money in second half of August after $3 billion inflow?Foreign portfolio investors poured over $3.2 billion into Indian equities in August, marking their strongest monthly inflow since September...
- Gland Pharma shares: Promoter Fosun Pharma likely to divest 5% equity worth Rs 2,279 crore via block dealFosun Pharma plans to divest 5% equity in Gland Pharma through a Rs 2,279.5 crore block deal at Rs 2,763 per share. Gland Pharma reported a...
- Commerce Minister to inaugurate Pharma MachTech & LabNext Expo 2026 at Bharat MandapamSet to kick off on September 7, 2026, in Delhi, the Pharma MachTech & LabNext Expo 2026 aims to position India as a center of excellence fo...
Load More
